Skip to search formSkip to main contentSkip to account menu

aripiprazole lauroxil

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Objective Safety and tolerability of long-term treatment with the long-acting antipsychotic aripiprazole lauroxil (AL) were… 
2018
2018
Background and ObjectivesAripiprazole lauroxil (AL), a long-acting injectable antipsychotic for the treatment of schizophrenia… 
2018
2018
Nonadherence to antipsychotic medications for the treatment of schizophrenia is a widely recognized concern, leading to poorer… 
2017
2017
Background Aripiprazole lauroxil is an extended-release prodrug of aripiprazole for intramuscular injection, approved for… 
2017
2017
OBJECTIVE To evaluate durability of therapeutic effect of long-term treatment with aripiprazole lauroxil in patients with… 
2017
2017
BackgroundAripiprazole lauroxil (AL) is a long-acting injectable medication approved for the treatment of schizophrenia. Current… 
2016
2016
This study aimed to evaluate the effects of aripiprazole lauroxil on hostility and aggressive behavior in patients with… 
2016
2016
OBJECTIVE Aripiprazole lauroxil, a long-acting injectable antipsychotic, demonstrated safety and efficacy in treating symptoms of… 
Review
2016
Review
2016
  • L. Citrome
  • Expert review of clinical pharmacology
  • 2016
  • Corpus ID: 207208248
ABSTRACT Aripiprazole monohydrate (AM) and aripiprazole lauroxil (AL) are two different long-acting injectable formulations of… 
Highly Cited
2015
Highly Cited
2015
OBJECTIVE This study evaluated the efficacy, safety, and tolerability of aripiprazole lauroxil, a novel long-acting injectable…